Resident cardiac stem cells: how to find and use them

Similar documents
SUPPLEMENTARY INFORMATION

Stem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford

DOWNLOAD PDF CARDIAC REMODELING AND CELL DEATH IN HEART FAILURE

Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan

The Jay Cohn Lecture 2012: Therapeutic regeneration of the injured heart

Cell Combination Therapy. Disclosures

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

Supporting Information. Calculation of the relative contributions of myocyte proliferation, stem cell. Supporting Information Fig 1 (page 9)

Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK

Heart Development. Robert G. Kelly Developmental Biology Institute of Marseilles - Luminy

Myocardial Regeneration and Stem Cell Repair

Heart Development. Origins of congenital heart defects Properties of cardiac progenitor cells. Robert G. Kelly

Translating Molecular Insights Into New Cellular Therapies For Cardiovascular Disease

Regenerative Medicine for Cardiomyocytes

Cell-based therapy for prevention and reversal of myocardial remodeling

Stem cells: units of development and regeneration. Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research.

9/23/2017. Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

ENGINEERING THREE DIMENSIONAL CARDIOSPHERES FROM PLURIPOTENT STEM CELLS

Myocardial infarction

1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism

Progress in clinical applications of PSCs in The bench to bedside pathway

Devices are So Old School: The New World of Myocardial Regeneration

The concept of regenerative medicine using the body s

E. Cervio, P. Danieli, C. Ciuffreda, F. Pisano, M. Roccio, M. Gnecchi. The authors have no financial disclosures to declare

Stem Cell Therapy for Heart Disease Revisited: the Paracrine Paradigm

International Graduate Research Programme in Cardiovascular Science

Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart

Cardiovascular Stem Cell Therapy

Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells

Stem cells for cardiac repair

Domenico D Amario MD, PhD Università Cattolica del Sacro Cuore Rome:

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features

Probe. Hind III Q,!&#12?R'!! /0!!!!D1"?R'! vector. Homologous recombination

Cardiac Stem Cells and Mechanisms of Myocardial Regeneration

Research progress of adult stem cells and clinical applications

Myocyte Derived Cardiac Spheroids for Post Infarct Cardiac Regeneration

ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM

NIH Public Access Author Manuscript Science. Author manuscript; available in PMC 2010 July 2.

Stem cell therapy aimed at restoring organ function,

Protocol. Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia

Review. Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease

Review Article Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora s Box

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

The official electronic file of this thesis or dissertation is maintained by the University Libraries on behalf of The Graduate School at Stony Brook

Clinical Applications of Stem Cell Therapy for Regenerating The Heart

Improving Cardiac Repair by Stem Cell Factor Post-Myocardial Infarction

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

Cardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart

Side Population cells possess a stem cell nature: cytoprotection, proliferation, and role of functional recovery in the murine heart

REVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells

THESIS. ROMANIAN ACADEMY Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest

Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration

Hematopoiesis. - Process of generation of mature blood cells. - Daily turnover of blood cells (70 kg human)

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II FACOLTA DI MEDICINA E CHIRURGIA

Haematopoietic stem cells

TISSUE-SPECIFIC PROGENITOR AND STEM CELLS

MicroRNA as a Biological Drug and Recovery of Myocardial Infarction. Exosome

REGENERATIVE MEDICINE

Follow-up of the CUPID Gene Therapy Trials

Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction

Review Article Therapeutic Application of Cardiac Stem Cells and Other Cell Types

Medical Coverage Policy Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia

University of Milano-Bicocca School of medicine and faculty of science

NIH Public Access Author Manuscript Circulation. Author manuscript; available in PMC 2011 January 19.

Reprogramming through micrornas Stefanie Dimmeler

European Society of Cardiology Congress DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS

Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model

Cardiac Gene Therapy: Beyond the Mouse. David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA

Ischaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast

Cardiac repair with thymosin 4 and cardiac reprogramming factors

CSP. Cardiopulmonary Support and Physiology

Extending the time window of mammalian heart regeneration by thymosin beta 4

Human Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Introduction Kit Components Cat. # # of vials Reagent Quantity Storage

Regeneration Gaps Observations on Stem Cells and Cardiac Repair

Multimodality Imaging in Cardiac Stem Cell Research

Cardiovascular cell therapy: next step is a custom work?

Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years ( )

Journal of the American College of Cardiology Vol. 59, No. 10, by the American College of Cardiology Foundation ISSN /$36.

Effects of reference compounds on impedance signals from stem cellderived human cardiomyocytes

Review Article Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart?

Supplementary Figure 1. Spatial distribution of LRP5 and β-catenin in intact cardiomyocytes. (a) and (b) Immunofluorescence staining of endogenous

c-kit Stem Cell Therapy of Ischemic Cardiomyopathy

Increasing the Presence of Cell Cycle Markers in Adult Cardiac Myocytes for the Treatment of Myocardial Infarction

Erythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy

Citation for published version (APA): Velde, S. V. D. (2006). Stem cell-mediated regeneration of the infarcted heart: inflammation rules? s.n.

Cell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory

Myocyte turnover occurs in the human heart, and myocyte

Induced Pluripotent Stem Cells: an Introduction Oren Caspi MD, PhD

Significant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs

Stem Cells as a therapy for myocardial infarction in animal models

Reviews. This Review is part of a thematic series on Cellular Therapy, which includes the following articles:

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

Exercise in Adverse Cardiac Remodeling: of Mice and Men

FOCUS ON CARDIOVASCULAR DISEASE

E10.5 E18.5 P2 10w 83w NF1 HF1. Sham ISO. Bmi1. H3K9me3. Lung weight (g)

Review. Current perspective of stem cell therapies for cardiac regeneration. Yee Ki Lee 1, Chung-Wah Siu 1,2, Yang Zhang 1 & Hung-Fat Tse 1,2

Muscle Stem Cells in Regeneration

Review. This Review is part of a thematic series on Stem Cells, which includes the following articles:

Review Article Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy

Heart Regeneration: More Hope, Less Hype

Transcription:

Resident cardiac stem cells: how to find and use them G. Hasenfuß Cardiology and Pneumology Heart Research Center Göttingen Georg-August-University Göttingen

Definition: Stem cell Selfrenewal Stem cell Differentiation Proliferation Pluripotency: Potential for differentiation into all cells of the body

Bone marrow stem cells Bone marrow cells regenerate infarcted rat hearts C-kit +, lineage-negative EGFP mouse bone marrow cells in rat hearts 3-5h after infarction. 9 Days after injection myocytes and vascular cells: Transdifferentiation Orlic et al., Nature 2001

Lack of transdifferentiation of bone marrow cells into cardiomyocytes Bone-marrow-derived haematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation Nygren et al., Nat. Med 2004 Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Murry et al., Nature 2004 Haematopoietic stem cells adopt mature haematopoietic fates in ischemic myocardium Balsam et al., Nature 2004 After 6 weeks cell-treated mice showed a statistically significant, although modest, improvement of fractional shortening, and left ventricular dimensions

Cardiomyogenic stem cells mouse heart Blastocysts Brachyury Precursors Precardiac mesoderm Embryos MSP; Flk +/- RV, OT, RA, LA ES Cells EC Cells EG Cells Embryonic Heart Isl1; Nkx2.5; c-kit+ LV, RA, LA Cardiac progenitor cells Cardiac commitment Myocytes, VSNC, EC Neonatal Heart Adult Heart Sca 1 c-kit Side Population Cardiosphere L. Field

Cardiac stem cells in mice Green: c-kit pos White: NKx2,5 Blue: nuclei Red: -actin Sca1 cells: Oh et al. PNAS 2003 SP cells: Martin et al. Dev Biol 2004 ATP-binding cassette transporter ABCG2 Beltrami et al., Cell 2003

Human resident cardiac stem cells?

Human Cardiospheres from biopsies Atrial and ventricular biopsies during cardiac surgery Trypsin digestion, culture of tissue fragments for 1-3 weeks Adherent fibroblast-like cells migrating small, phase-bright cells c-kit + Cardiac Markers Collection of phase-bright cells (4x within 6-10 days) Passage of CSs every 2-3 days Immunofluorescence: ctni, ANP, MHC (external layers), CD34, C-kit, Sca1 and others (c-kit = BrdU incorporation) Messina et al., Circ Res 2004

Cardiosphere-derived cells from percutaneous endomyocardial biopsis RV endomyocardial biopsis from transplant and nontransplant patients 70 pts. 1.7± 0.4 x 10 6 CDCs per patient (in 69/70) C-kit, CD105, Ki67 (center), connexin43, α sarcomeric actin different from bone marrow derived C-kit + cells CDCs contain subpopulations with mesenchymal cells, fibroblasts No spontaneous contractions Co-culture to obtain beating cells Smith et al., Circulation 2007

Injection of CDCs in mouse heart Immunofluorescence after 20 days Improvement of function in infarcted hearts Smith et al., Circulation 2007

Autologous CDCs in Porcine ICM Endomyocardial biopsies from pigs Intracoronary infusion 4 weeks after MI CDCs versus placebo 94 % biopsy success (52.6 ± 6.7 mg) 91 % success of CDCs generation 24.5 ± 2.9 x 10 6 cells in 2.7 ± 0.1 passages and 26.9 ± 1.3 days Johnston et al., Circulation 2009

Infarct size after 8 weeks Johnston et al., Circulation 2009

Contractile function after 8 weeks Johnston et al., Circulation 2009

Cardiospheres open Questions Diffentiation into cardiomyocytes? Clinical studies are being performed Messina et al., Circ Res 2004

Human Cardiomyocyte progenitor cells (CMPCs) (Sca-1 based) LA Collagenase Smits et al., Nat Prot 2009

Cardiomyocyte progenitor cells (CMPCs) (Sca-1 based) Magnetic cell sorting: iron-labeled mouse Sca-1 AB [Sca-1 not expressed from human cells, however population of human cells is isolated, cross-reaction of AB with unknown protein] Rapid cell devision with 1 / day for 75 passages Differentiation into cardiomyocytes only with 5 Azacytidine (5 aza induces genome-wide demethylation) Smits et al., Nat Prot 2009

C-kit + human cardiac stem cells (hcscs) 1% c-kit + cadiac niches Myocardial biopsies Enzymatic digestion cell sorting with immunobeads based on c-kit-ab cell culture outgrow of c-kit + cells immunocytochemistry (3 weeks) sucess in 8 / 12 and 46 / 70 cases 1 % c-kit + cells Expression of myocyte markers no beating cardiomyocytes Injection of cells into mouse hearts with MI regeneration with new human myocytes and capillaries Bearzi et al., PNAS 2007

Myocardium control heart within 24h after death c-kit MDR1 Sca-1 Urbanek et al., PNAS 2003

Myocardium from outflow tract during valve replacement Urbanek et al., PNAS 2003

C-kit-positive cells Pouly et al., J Thor and CV Surgery 2007

C-kit-positive cells Pouly et al., J Thor and CV Surgery 2007

Cardiac stem cells in the real world 32 endomyocardial biopsies from heart transplant recipients 18 RA appendages 2.7 c-kit-positive cells / mm 2 in EM biopsies 1 c-kit-positive cell / mm 2 in RA tissue all c-kit-positive cells co-stained for CD45 and expressed tryptase as a specific mast cell marker no expression of stemness markers Pouly et al., J Thor and CV Surgery 2008

Summary No proof of cardiomyocyte differentiation of resident cardiac stem cells from human heart (without being brutal!) No convincing data against hypothesis that c-kit-positive cells are mast cells and that cardiospheres contain cardiomyocytes as carry over. Wait for clinical studies with cardiospheres